Status:
RECRUITING
Effect of Phlebotomy on Heartrate in Polycythemia Patients
Lead Sponsor:
Leiden University Medical Center
Conditions:
Polycythemia
Eligibility:
All Genders
18+ years
Brief Summary
Single-centre, observational within-subject design: patients that undergo phlebotomies regularly for polycythemia will be measured continuously by wearables one week before until one week after a phle...
Detailed Description
Rationale: Little is known about the effect of a hemoglobin-shift on patients, anaemic, non-anaemic or even polycythaemic. It has been established that severe anaemia has deteriorating effects on the ...
Eligibility Criteria
Inclusion
- Patients with polycythaemia, requiring phlebotomy on a regular basis (at least every 4 months)
- Subjects aged ≥18 years
- In possession of a smartphone
- Life expectancy ≥ 3 months
Exclusion
- Poor performance/functional status (Eastern Cooperative Oncology Group system ECOG ≥3)
- Participants with known arrhythmias or other significant cardiological conductivity disorders (Paroxysmal atrial fibrillation is allowed)
- Hospitalized subjects
- Subjects with a pacemaker.
- Subjects with a secondary polyglobulia due to eg smoking or other pulmonary issues.
- Scheduled oncological treatments or surgery during the study period.
Key Trial Info
Start Date :
July 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05396170
Start Date
July 21 2022
End Date
January 1 2025
Last Update
November 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LUMC
Leiden, South Holland, Netherlands